Abstract
We evaluated performance of single-nucleotide polymorphism (SNP)-based cell-free DNA (cfDNA) screening for trisomies 13, 18, and 21 in a large unselected prospective cohort with genetic confirmation. We hypothesized equivalent performance to published studies without genetic confirmation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
